KCM
CRL icon

Kornitzer Capital Management’s Charles River Laboratories CRL Stock Holding History

Kornitzer Capital Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-36,800
Closed -$7.43M – 486
2023
Q1 		$7.43M Hold
36,800
– – 0.15% 214
2022
Q4 		$8.02M Sell
36,800
-26,176
-42% -$5.72M 0.16% 194
2022
Q3 		$12.4M Sell
62,976
-3,439
-5% -$742K 0.27% 113
2022
Q2 		$14.2M Hold
66,415
– – 0.28% 110
2022
Q1 		$18.9M Hold
66,415
– – 0.31% 105
2021
Q4 		$25M Hold
66,415
– – 0.37% 83
2021
Q3 		$27.4M Sell
66,415
-8,560
-11% -$3.56M 0.42% 66
2021
Q2 		$27.7M Hold
74,975
– – 0.42% 68
2021
Q1 		$21.7M Buy
74,975
+36,775
+96% +$10.2M 0.35% 101
2020
Q4 		$9.54M Buy
+38,200
New +$9.1M 0.16% 206
2017
Q1 		– Sell
-132,231
Closed -$10.1M – 469
2016
Q4 		$10.1M Hold
132,231
– – 0.19% 173
2016
Q3 		$11M Sell
132,231
-470
-0.4% -$39.4K 0.2% 178
2016
Q2 		$10.9M Sell
132,701
-34,182
-20% -$2.82M 0.2% 165
2016
Q1 		$12.7M Buy
166,883
+3,025
+2% +$224K 0.22% 156
2015
Q4 		$13.2M Sell
163,858
-28,667
-15% -$2.07M 0.22% 160
2015
Q3 		$12.2M Buy
192,525
+7,430
+4% +$534K 0.19% 170
2015
Q2 		$13M Buy
185,095
+7,195
+4% +$532K 0.18% 167
2015
Q1 		$14.1M Hold
177,900
– – 0.17% 153
2014
Q4 		$11.3M Sell
177,900
-400
-0.2% -$25.1K 0.13% 175
2014
Q3 		$10.7M Sell
178,300
-200
-0.1% -$11.4K 0.12% 180
2014
Q2 		$9.55M Sell
178,500
-800
-0.4% -$43.9K 0.1% 199
2014
Q1 		$10.8M Buy
179,300
+3,700
+2% +$216K 0.11% 195
2013
Q4 		$9.31M Hold
175,600
– – 0.1% 213
2013
Q3 		$8.12M Hold
175,600
– – 0.1% 194
2013
Q2 		$7.21M Buy
+175,600
New +$7.52M 0.09% 202

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Kornitzer Capital Management's CRL Position: Q2 2023 in Review

Kornitzer Capital Management sold out of Charles River Laboratories (CRL) in Q2 2023, closing a stake of 36,800 shares — an estimated $7.43M sold.

Kornitzer Capital Management first reported a position in CRL in Q2 2013 and held it in 25 quarters. The position peaked at $27.7M in Q2 2021. 611 funds tracked by Wall St. Rank hold CRL as of Q2 2023.

  • Kornitzer Capital Management reported no remaining Charles River Laboratories position as of Q2 2023 after selling out during the quarter.
  • Kornitzer Capital Management sold 36,800 Charles River Laboratories shares in Q2 2023, an estimated $7.43M.
  • Kornitzer Capital Management first reported a position in Charles River Laboratories in Q2 2013 and held it in 25 quarters.
  • Kornitzer Capital Management's Charles River Laboratories position peaked at $27.7M in Q2 2021.
  • 611 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2023.

Based on Kornitzer Capital Management's 13F filing for Q2 2023, filed 1 Aug 2023.